Rembrandt trial.

Recognising Effective Materials By Randomising & Assessing New Donorsite Treatments.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON21630

Enrollment

250

Registered

2009-06-09

Start date

2009-10-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

donor site of split-thickness skin graft bandages wound healing

Interventions

One of the following wound dressings will be randomly applied: 1. Paraffin gauze

2. Film

3. Hydrocolloid

4. Alginate

5. Silicone.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adults; 2. Condition requiring split-skin grafting; 3. Donor site of at least 10 cm2; 4. Written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients physically or mentally not able to consent; 2. Patients with impaired wound healing (e.g. chemotherapy).

Design outcomes

Primary

Measure	Time frame
Time to complete wound healing.	—

Secondary

Measure	Time frame
1. Pain; 2. Infection rate; 3. Itching; 4. Patient comfort; 5. Costs.	—

Contacts

Public ContactH. Vermeulen

Academic Medical Center (AMC), Department of Surgery, G4-233, P.O. Box 22660

H.Vermeulen@amc.uva.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)